Clinical Trial: Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
Study Status: Completed
Recruit Status: RECRUITING
Condition: Thromboembolism
Study Type: INTERVENTIONAL
Official Title: A Pilot Randomized Controlled Trial of Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery
Brief Summary:
The aim of this study is to evaluate the feasibility of randomizing individuals to low molecular weight heparin (enoxaparin) or no treatment following cesarean delivery.The investigators hypothesize that among eligible individuals, at least 35% will enroll, undergo randomization, and complete the allocated treatment group.
Read more